Haemonetics Welcomes New FDA Guidance on Viscoelastic Testing During COVID-19 Pandemic

BOSTON, Jan. 22, 2021 /PRNewswire/ — Haemonetics Corporation (NYSE: HAE) (“Haemonetics”), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, affirms its support of new guidance issued by the U.S. Food and Drug…

No Comments

No comments yet.

Sorry, the comment form is closed at this time.